Physician profile
Ahmad Elbash
NPI 1770797466
$48,184.05
in general payments reported to CMS, 2019-2025
40 companies · $31K in 2025
The $31K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,321 · 2020: $900 · 2021: $757 · 2022: $2,587 · 2023: $1,870 · 2024: $9,971 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $38K · Food and Beverage: $3,669 · Travel and Lodging: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $38,250.00 |
| Food and Beverage | $3,669.41 |
| Travel and Lodging | $699.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $39,362.27 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $1,644.16 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,469.16 | 2019-2025 | General - Stents, Wolverine Coronary Cutting Balloon, Comet |
| Inari Medical, INC. | $979.37 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Celonova Biosciences, INC. | $879.52 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $682.59 | 2020-2025 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $579.57 | 2019-2024 | |
| Abbott Laboratories | $444.74 | 2019-2025 | Aveir |
| Pfizer INC. | $206.58 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $178.68 | 2021-2023 | Xarelto |
| Amarin Pharma, INC. | $149.80 | 2019-2022 | |
| Stryker Corporation | $145.77 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Alnylam Pharmaceuticals INC. | $119.67 | 2022-2024 | Onpattro |
| Amgen INC. | $117.12 | 2020-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.89 | 2019-2024 | Jardiance |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.41 | 2019-2024 | Lifevest |
| Medtronic, INC. | $96.08 | 2022-2024 | Abre, Onyx Frontier |
| Actelion Pharmaceuticals US, INC. | $93.13 | 2021-2025 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $86.01 | 2024-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $73.77 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $73.66 | 2024-2025 | Verquvo, Capvaxive |
| Scpharmaceuticals INC. | $72.97 | 2023-2024 | |
| Novo Nordisk INC | $64.69 | 2023-2025 | Ozempic |
| Avanir Pharmaceuticals, INC. | $48.25 | 2019 | |
| Lantheus Medical Imaging, INC. | $47.42 | 2023-2025 | Definity |
| Daiichi Sankyo INC. | $42.17 | 2021-2023 | Injectafer |
| Shockwave Medical, INC | $41.14 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Imperative Care, INC | $40.85 | 2025 | Symphony Catheter |
| Cardiovascular Systems INC. | $30.97 | 2021 | |
| Tactile Systems Technology INC | $29.69 | 2025 | Flexitouch Plus, Nimbl |
| Altathera Pharmaceuticals LLC | $26.17 | 2023-2024 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals International, Plc | $25.56 | 2024 | Arcalyst |
| Cvrx, INC. | $19.35 | 2022-2023 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $18.83 | 2025 | |
| Philips North America LLC | $18.77 | 2019 | |
| Inspire Medical Systems, INC. | $15.84 | 2024 | Inspire |
| Lilly USA, LLC | $14.90 | 2025 | Zepbound, Mounjaro |
| Chiesi USA, INC. | $13.02 | 2021 | |
| Gilead Sciences, INC. | $12.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Elbash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.